# US 2004/0204455 A1 · Piperidine derivative rennin inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0204455 A1
- Document ID: US20040204455A1
- Status: Published application
- Kind: A1
- Application number: 10/811,200
- Filed: 2004-03-26
- Published: 2004-10-14
- Earliest claimed: 2003-04-10
- Inventors: Wayne Livingston Cody; Jeremy John Edmunds; Daniel Dale Holsworth; Noel Aaron Powell
- Web page: https://patentgrep.com/patent/US20040204455A1

## CPC

- C07D 401/12: linked by a chain containing hetero atoms as chain links
- A61P 9/12: Antihypertensives
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 211/56: Nitrogen atoms (nitro radicals C07D211/38)
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed are piperidine derivatives, their manufacture and use as inhibitors of renin.

## Claims

### Claim 1

A compound of Formula I
54
or a pharmaceutically acceptable salt thereof, wherein
R1 and R2 are independently hydrogen or unsubstituted C1-C3 alkyl;
R3 is hydrogen, oxo, or thioxo;
R0 is hydrogen or unsubstituted C1-C3 alkyl provided that when R3 is oxo or thioxo R0 is absent;
R4, R5, R6, and R7 are independently hydrogen, halogen, carboxyl, substituted or unsubstituted C1-C3 alkoxy, or substituted or unsubstituted C1-C3 alkyl;
Q is —NR8—(CH2)0-6—, —NR9—C(O)—(CH2)0-6—, wherein 1 to 3 nonadjacent methylene units are replaced with O, NR11, S or a combination thereof;
T is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted C1-C12 alkyl
W is absent, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
Z is —(CH2)0-6-cycloalkylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6-heterocycloalkylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6-arylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6-heteroarylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6—C(O)—NR11—(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6—NR11—C(O)—(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof,
55
wherein 1 to 6 nonadjacent
56
units are replaced with O, NR12, S or a combination thereof, or
Z, when W is absent, is hydroxyl, substituted or unsubstituted C1-C12 alkyl wherein 1 to 6 nonadjacent methylene units are replaced with O, NR16, S or a combination thereof, or —(CH2)0-6—C(O)—NR16-(CH2)0-5—CH3 wherein 0 to 6 nonadjacent methylene units are replaced with O, NR16, S or a combination thereof;
R8, R9 and R10 are independently hydrogen or substituted or unsubstituted C1-C3 alkyl;
R11 and R12 are independently substituted or unsubstituted C1-C3 alkyl; and
R14 and R15 are independently hydrogen, substituted or unsubstituted C1-C3 alkoxy, substituted or unsubstituted C1-C3 alkyl, unsubstituted C1-C12 alkyl wherein 1 to 6 nonadjacent methylene units are replaced with 0, or R14 and R15 together with the carbon to which they are attached form a 3- to 6-membered cycloalkylene or heterocycloalkylene ring; and
R16 is substituted or unsubstituted C1-C3 alkyl or hydrogen.

### Claim 2 (depends on 1)

A compound of claim 1, wherein R1 and R2, are hydrogen and R3 is oxo.

### Claim 3 (depends on 1)

A compound of claim 1, wherein R4, R5, R6, and R7 are independently hydrogen, halogen, carboxyl, C1-C3 alkoxy, or C1-C3 alkyl.

### Claim 4 (depends on 3)

A compound of claim 3, wherein R4, R5, R6, and R7 are independently hydrogen, chlorine, fluorine, carboxyl, methoxy or methyl.

### Claim 5 (depends on 1)

A compound of claim 1, wherein R4, R6, and R7 are hydrogen and R5 is chlorine, fluorine, carboxyl, methoxy or methyl.

### Claim 6 (depends on 1)

A compound of claim 1, wherein Q is —NR8—(CH2)0-6—, or —NR9—C(O)—(CH2)0-6— wherein R8 and R9 are independently unsubstituted C1-C3 alkyl.

### Claim 7 (depends on 6)

A compound of claim 6, wherein Q is —NH—(CH2)0-6—, or —NH—C(O)—(CH2)0-6—.

### Claim 8 (depends on 7)

A compound of claim 7, wherein Q is —NH—CH2—, —NH—CH2—CH2—, —NH—CH2—CH2—O—CH2—, or —NH—CH2—CH2—O—.

### Claim 9 (depends on 1)

A compound of claim 1, wherein T is unsubstituted aryl.

### Claim 10 (depends on 1)

A compound of claim 1, wherein T is unsubstituted phenyl, naphthyl, biphenyl, 1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro-naphthyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydroquinoxalinyl, or 1,2,3,4-tetrahydroindolyl.

### Claim 11 (depends on 10)

A compound of claim 10, wherein T is 2-naphthyl, biphen-4-yl, 1,2,3,4-tetrahydroquinolin-6-yl, or 1,2,3,4-tetrahydroquinolin-7-yl.

### Claim 12 (depends on 1)

A compound of claim 1, wherein T is substituted aryl

### Claim 13 (depends on 12)

A compound of claim 12, wherein T is substituted phenyl, naphthyl, biphenyl, 1,2,3,4-tetrahydroquinolinyl, 2-oxo-1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro-naphthyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydroquinoxalinyl, 1,2,3,4-tetrahydroindolyl, 2,3-dihydroindolyl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazinyl, or 3,4-dihydro-2H-benzo[1,4]oxazinyl.

### Claim 14 (depends on 12)

A compound of claim 12, wherein T is phenyl substituted from 1 to 5 times with C1-C6alkyl, halo, C1-C6alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—NR16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16—(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16-(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 15 (depends on 14)

A compound of claim 14, wherein T is 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3,4-difluorophenyl, 3,5-difluorophenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 3,4-dimethoxyphenyl, 3,5-dimethoxyphenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 3,4-dimethylphenyl, 3,5-dimethylphenyl, 2-chloro-4-fluorophenyl, 4-fluoro-2-trifluoromethylphenyl, 2-(2-acetoxy-ethyl)-phenyl, 3-(2-acetoxy-ethyl)-phenyl, 4-(2-acetoxy-ethyl)-phenyl, N,N-dimethyl-benzamide-4-yl, or 4-acetylaminophenyl.

### Claim 16 (depends on 1)

A compound of claim 1, wherein T is biphenyl substituted from 1 to 9 times with C1-C6 alkyl, halo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16—(C_-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl) o—, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl) o—, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR1-S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 17 (depends on 1)

A compound of claim 1, wherein T is naphthyl, 1,2,3,4-tetrahydroquinolinyl, 2-oxo-1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydronaphthyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydroquinoxalinyl, 3,4-dihydro-2H-benzo[1,4]oxazinyl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazinyl, 2,3-dihydroindolyl, or 1,2,3,4-tetrahydroindolyl substituted from 1 to 7 times with, C1-C6 alkyl, halo, hydroxy, oxo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)_, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16—(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 18 (depends on 17)

A compound of claim 17, wherein T is 6-methoxy-2-naphthyl, 7-methoxy-2-naphthyl, 6-methyl-2-naphthyl, 6-hydroxy-2-naphthyl, 7-methyl-2-naphthyl, 6-trifluoromethyl-2-naphthyl, 7-trifluoromethyl-2-naphthyl, 6-fluoro-2-naphthyl, 7-fluoro-2-naphthyl, 6-chloro-2-naphthyl, 7-chloro-2-naphthyl, 6-(2-acetoxy-ethyl)-2-naphthyl, 7-(2-acetoxy-ethyl)-2-naphthyl, 1-(3-hydroxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-acetyl-3,4-dihydro-2H-quinolin-6-yl, 1-(4-thiazolylmethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-7-yl, or 1-(2-acetoxy-ethyl)-3,4-dihydro-2H-quinolin-7-yl.

### Claim 19 (depends on 1)

A compound of claim 1, wherein T is unsubstituted naphthyl, unsubstituted 4-trifluoromethylphenyl, unsubstituted 1,2,3,4-tetrahydroquinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-5-indolyl, 1-(2-acetylaminoethyl)-5-indolyl, 1-(3-methoxypropyl)-5-indolyl, 1-acetamidyl-5-indolyl, 1-(2-acetoxyethyl)-5-indolyl, 1-(3-methoxy-3-oxopropyl)-5-indolyl, 1-(2-methoxy-2-oxoethyl)-5-indolyl, 1-(2-ethoxy-2-oxoethyl)-6-indolyl, 1-(2-acetylaminoethyl)-6-indolyl, 1-(3-methoxypropyl)-6-indolyl, 1-acetamidyl-6-indolyl, 1-(2-acetoxyethyl)-6-indolyl, 1-(3-methoxy-3-oxopropyl)-6-indolyl, 1-(2-methoxy-2-oxoethyl)-6-indolyl, 4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(3-methoxypropyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-acetylaminoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-acetamidyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-acetoxyethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(3-methoxy-3-oxopropyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-methoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 1-(3-hydroxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-hydroxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-acetyl-3,4-dihydro-2H-quinolin-6-yl, 1-acetyl-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(4-thiazolylmethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-6-yl, 1-acetamidyl-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetylaminoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxy-3-oxopropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetylaminoethyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxy-3-oxopropyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxypropyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-6-yl, 2-oxo-1,2,3,4-tetrahydro-2H-quinolin-7-yl, 2-oxo-1,2,3,4-tetrahydro-2H-quinolin-6-yl, 1-(2-acetylaminoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxy-3-oxopropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetylaminoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxy-3-oxopropyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-ethoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetoxyethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetoxyethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetoxyethyl)-3,4-dihydro-2H-quinolin-6-yl or 1-(2-acetoxyethyl)-3,4-dihydro-2H-quinolin-7-yl.

### Claim 20 (depends on 1)

A compound of claim 1, wherein T is unsubstituted heteroaryl.

### Claim 21 (depends on 20)

A compound of claim 20, wherein T is quinolinyl, indolyl, benzofuryl, isoquinolinyl, pyridyl, pyrimidinyl, pyrazinyl, or quinoxalinyl.

### Claim 22 (depends on 21)

A compound of claim 21, wherein T is 2-quinolinyl, 6-quinolinyl, 7-quinolinyl, 6-isoquinolinyl, 2-pyridyl, 5-benzofuryl, 2-pyrimidinyl, 2-pyrazinyl, or 2-quinoxalinyl.

### Claim 23 (depends on 1)

A compound of claim 1, wherein T is substituted heteroaryl.

### Claim 24 (depends on 23)

A compound of claim 23, wherein T is substituted quinolinyl, indolyl, benzofuryl, isoquinolinyl, pyridyl, pyrimidinyl, pyrazinyl, or quinoxalinyl.

### Claim 25 (depends on 24)

A compound of claim 24, wherein T is quinolinyl, isoquinolinyl or quinoxalinyl substituted from 1 to 7 times with C1-C6 alkyl, halo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16-(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 26 (depends on 24)

A compound of claim 24, wherein T is pyridyl, indolyl, pyrimidinyl, or pyrazinyl, substituted from 1 to 5 times with C1-C6 alkyl, halo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16—(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1, (C1-C6 alkyl)-NR16-S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 27 (depends on 1)

A compound of claim 1, wherein T is N-substituted 1,2,3,4-tetrahydroquinolin-7-yl, N-substituted 1,2,3,4-tetrahydroquinolin-6-yl, N-substituted 2-oxo-1,2,3,4-tetrahydroquinolin-7-yl, N-substituted 2-oxo-1,2,3,4-tetrahydroquinolin-6-yl, N-substituted 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, N-substituted 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-7-yl, N-substituted 2-oxo-4a,8a-dihydro-2H-chromen-7-yl, N-substituted 2,3-dihydroindol-6-yl, N-substituted 2-oxo-2,3-dihydroindol-6-yl, N-substituted 2,3-dihydroindol-5-yl, N-substituted 2-oxo-2,3-dihydroindol-5-yl, N-substituted 6-indolyl or N-substituted 5-indolyl.

### Claim 28 (depends on 27)

A compound of claim 27, wherein the N-substituent is C1-C6 alkyl, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16-(C1-C6 alkyl) ol-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl.

### Claim 29 (depends on 1)

A compound of claim 1, wherein Z is
57
wherein 1 to 6 nonadjacent
58
units are replaced with 0.

### Claim 30 (depends on 1)

A compound of claim 1, wherein R14 and R15 are hydrogen.

### Claim 31 (depends on 1)

A compound of claim 1, wherein Z is
—(CH2)0-6—C(O)—NR11—(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof; or
—(CH2)0-6—NR11—(C(O)—CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof; and
R11 and R12 are as defined in claim 1.

### Claim 32 (depends on 1, 29)

A compound of claim 29, wherein Z is —O—(CH2)2-3—O—(CH2)1-2—, —O—(CH2)3-4—O—, O—(CH2)1-2-, —(CH2)—O—(CH2)2-3—O—(CH2)0-1-, —C(O)—NR11—(CH2)2—, —C(O)—NR11—(CH2)2—O—, or —O—(CH2)3—S—(CH2)1—; and
R11 is as defined in claim 1.

### Claim 33 (depends on 1)

A compound of claim 1, wherein when W is absent, Z is hydroxyl, C1-C12 alkyl wherein 1 to 6 nonadjacent methylene units are replaced with O, or —(CH2)0-6—C(O)—NR16—(CH2)0-5—CH3 wherein 0 to 6 nonadjacent methylene units are replaced with O; and
R16 is as defined in claim 1.

### Claim 34 (depends on 1)

A compound of claim 1, wherein Z is —O—(CH2)3—O—(CH2)—.

### Claim 35 (depends on 1)

A compound of claim 1, wherein W is unsubstituted or substituted phenyl.

### Claim 36 (depends on 1)

A compound of claim 1, wherein W is 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3,4-difluorophenyl, 3,5-difluorophenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 3,4-dimethoxyphenyl, 3,5-dimethoxyphenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 3,4-dimethylphenyl, 3,5-dimethylphenyl, 2-chloro-4-fluorophenyl, 4-fluoro-2-trifluoromethylphenyl, 2-(2-acetoxy-ethyl)-phenyl, 3-(2-acetoxy-ethyl)-phenyl, 4-(2-acetoxy-ethyl)-phenyl, N,N-dimethyl-benzamide-4-yl, or 4-acetylaminophenyl.

### Claim 37 (depends on 1)

A compound of claim 1, wherein W is 2-methoxyphenyl.

### Claim 38 (depends on 1)

A compound of claim 1, wherein W is unsubstituted or substituted heteroaryl

### Claim 39 (depends on 38)

A compound of claim 38, wherein W is unsubstituted indolyl.

### Claim 40 (depends on 39)

A compound of claim 39, wherein W is 1H-Indol-3-yl.

### Claim 41 (depends on 1)

A compound of claim 1, wherein Z is —O—(CH2)3—O—CH2—, and W is 2-methoxyphenyl.

### Claim 42 (depends on 1)

A compound of claim 1, wherein Q is —NH—CH2— or —NR8—CH2—; T is unsubstituted naphthyl, unsubstituted 4-trifluoromethylphenyl, unsubstituted 1,2,3,4-tetrahydroquinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-5-indolyl, 1-(2-acetylaminoethyl)-5-indolyl, 1-(3-methoxypropyl)-5-indolyl, 1-acetamidyl-5-indolyl, 1-(2-acetoxyethyl)-5-indolyl, 1-(3-methoxy-3-oxopropyl)-5-indolyl, 1-(2-methoxy-2-oxoethyl)-5-indolyl, 1-(2-ethoxy-2-oxoethyl)-6-indolyl, 1-(2-acetylaminoethyl)-6-indolyl, 1-(3-methoxypropyl)-6-indolyl, 1-acetamidyl-6-indolyl, 1-(2-acetoxyethyl)-6-indolyl, 1-(3-methoxy-3-oxopropyl)-6-indolyl, 1-(2-methoxy-2-oxoethyl)-6-indolyl, 4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(3-methoxypropyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-acetylaminoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-acetamidyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-acetoxyethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(3-methoxy-3-oxopropyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-methoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 1-(3-hydroxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-hydroxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-acetyl-3,4-dihydro-2H-quinolin-6-yl, 1-acetyl-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(4-thiazolylmethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-6-yl, 1-acetamidyl-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetylaminoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxy-3-oxopropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetylaminoethyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxy-3-oxopropyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxypropyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-6-yl, 2-oxo-1,2,3,4-tetrahydro-2H-quinolin-7-yl, 2-oxo-1,2,3,4-tetrahydro-2H-quinolin-6-yl, 1-(2-acetylaminoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxy-3-oxopropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetylaminoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxy-3-oxopropyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-ethoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetoxyethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetoxyethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetoxyethyl)-3,4-dihydro-2H-quinolin-6-yl or 1-(2-acetoxyethyl)-3,4-dihydro-2H-quinolin-7-yl; and R8 is C1-C3 alkyl.

### Claim 43 (depends on 1)

A compound of claim 1 having the formula II or III
59
or a pharmaceutically acceptable salt thereof, wherein
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R14, R15, R16, Q, T, Z, and W are as defined above in claim 1.

### Claim 44

A compound of Formula IV or V
60
or a pharmaceutically acceptable salt thereof, wherein
T is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
W is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and
R17 is hydrogen or C1-C3 alkyl.

### Claim 45 (depends on 44)

A compound of claim 44, wherein T is substituted aryl.

### Claim 46 (depends on 45)

A compound of claim 45, wherein T is substituted phenyl, naphthyl, biphenyl, 1,2,3,4-tetrahydroquinolinyl, 2-oxo-1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydro-naphthyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydroquinoxalinyl, 1,2,3,4-tetrahydroindolyl, 2,3-dihydroindolyl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazinyl, or 3,4-dihydro-2H-benzo[1,4]oxazinyl.

### Claim 47 (depends on 44)

A compound of claim 44, wherein T is naphthyl, 1,2,3,4-tetrahydroquinolinyl, 2-oxo-1,2,3,4-tetrahydroquinolinyl, 1,2,3,4-tetrahydronaphthyl, 1,2,3,4-tetrahydroisoquinolinyl, 1,2,3,4-tetrahydroquinoxalinyl, 3,4-dihydro-2H-benzo[1,4]oxazinyl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazinyl, 2,3-dihydroindolyl, or 1,2,3,4-tetrahydroindolyl substituted from 1 to 7 times with, C1-C6 alkyl, halo, hydroxy, oxo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16—(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 48 (depends on 44)

A compound of claim 44, wherein T is unsubstituted naphthyl, unsubstituted 4-trifluoromethylphenyl, unsubstituted 1,2,3,4-tetrahydroquinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-5-indolyl, 1-(2-acetylaminoethyl)-5-indolyl, 1-(3-methoxypropyl)-5-indolyl, 1-acetamidyl-5-indolyl, 1-(2-acetoxyethyl)-5-indolyl, 1-(3-methoxy-3-oxopropyl)-5-indolyl, 1-(2-methoxy-2-oxoethyl)-5-indolyl, 1-(2-ethoxy-2-oxoethyl)-6-indolyl, 1-(2-acetylaminoethyl)-6-indolyl, 1-(3-methoxypropyl)-6-indolyl, 1-acetamidyl-6-indolyl, 1-(2-acetoxyethyl)-6-indolyl, 1-(3-methoxy-3-oxopropyl)-6-indolyl, 1-(2-methoxy-2-oxoethyl)-6-indolyl, 4-(2-ethoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(3-methoxypropyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-acetylaminoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-acetamidyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-acetoxyethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(3-methoxy-3-oxopropyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 4-(2-methoxy-2-oxoethyl)-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, 1-(3-hydroxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-hydroxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-acetyl-3,4-dihydro-2H-quinolin-6-yl, 1-acetyl-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(4-thiazolylmethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-acetamidyl-3,4-dihydro-2H-quinolin-6-yl, 1-acetamidyl-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetylaminoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxy-3-oxopropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxypropyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetylaminoethyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxy-3-oxopropyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxypropyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(2-methoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-6-yl, 1-(2-ethoxy-2-oxoethyl)-3,4-dihydro-2H-quinolin-6-yl, 2-oxo-1,2,3,4-tetrahydro-2H-quinolin-7-yl, 2-oxo-1,2,3,4-tetrahydro-2H-quinolin-6-yl, 1-(2-acetylaminoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxy-3-oxopropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(3-methoxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-ethoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetylaminoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxy-3-oxopropyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(3-methoxypropyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-methoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-ethoxy-2-oxoethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetoxyethyl)-2-oxo-3,4-dihydro-2H-quinolin-6-yl, 1-(2-acetoxyethyl)-2-oxo-3,4-dihydro-2H-quinolin-7-yl, 1-(2-acetoxyethyl)-3,4-dihydro-2H-quinolin-6-yl or 1-(2-acetoxyethyl)-3,4-dihydro-2H-quinolin-7-yl.

### Claim 49 (depends on 44)

A compound of claim 44, wherein T is quinolinyl, isoquinolinyl or quinoxalinyl substituted from 1 to 7 times with C1-C6 alkyl, halo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16-(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 50 (depends on 44)

A compound of claim 44, wherein T is pyridyl, indolyl, pyrimidinyl, or pyrazinyl, substituted from 1 to 5 times with C1-C6 alkyl, halo, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16—(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16—S(O)2—(C1-C6 alkyl)0-1-, or HO—(C1C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl or a combination thereof.

### Claim 51 (depends on 44)

A compound of claim 44, wherein T is N-substituted 1,2,3,4-tetrahydroquinolin-7-yl, N-substituted 1,2,3,4-tetrahydroquinolin-6-yl, N-substituted 2-oxo-1,2,3,4-tetrahydroquinolin-7-yl, N-substituted 2-oxo-1,2,3,4-tetrahydroquinolin-6-yl, N-substituted 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl, N-substituted 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazin-7-yl, N-substituted 2-oxo-4a,8a-dihydro-2H-chromen-7-yl, N-substituted 2,3-dihydroindol-6-yl, N-substituted 2-oxo-2,3-dihydroindol-6-yl, N-substituted 2,3-dihydroindol-5-yl, N-substituted 2-oxo-2,3-dihydroindol-5-yl, N-substituted 6-indolyl or N-substituted 5-indolyl.

### Claim 52 (depends on 51)

A compound of claim 51, wherein the N-substituent is C1-C6 alkyl, C1-C6 alkyl wherein 1 to 3 nonadjacent carbons are replaced with O, NR16, S or a combination thereof, (C1-C6 alkyl)-C(O)—O—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-O—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—N(R16)—, (C1-C6 alkyl)-NR16—C(O)—(C1-C6 alkyl)0-1-, trifluoromethyl, (C1-C6 alkyl)-C(O)—NR16-(C1-C6 alkyl)0-1-, HO—C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-C(O)—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-S(O)2—NR16—(C1-C6 alkyl)0-1-, (C1-C6 alkyl)-NR16-S(O)2—(C1-C6 alkyl)-, or HO—(C1-C6 alkyl), wherein each R16 is independently H or C1-C6 alkyl.

### Claim 53 (depends on 44)

A compound of claim 44, wherein W is unsubstituted or substituted phenyl.

### Claim 54 (depends on 53)

A compound of claim 53, wherein W is 2-trifluoromethylphenyl, 3-trifluoromethylphenyl, 4-trifluoromethylphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3,4-difluorophenyl, 3,5-difluorophenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 3,4-dimethoxyphenyl, 3,5-dimethoxyphenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 3,4-dimethylphenyl, 3,5-dimethylphenyl, 2-chloro-4-fluorophenyl, 4-fluoro-2-trifluoromethylphenyl, 2-(2-acetoxy-ethyl)-phenyl, 3-(2-acetoxy-ethyl)-phenyl, 4-(2-acetoxy-ethyl)-phenyl, N,N-dimethyl-benzamide-4-yl, or 4-acetylaminophenyl.

### Claim 55 (depends on 44)

A compound of claim 44, wherein W is 2-methoxyphenyl.

### Claim 56 (depends on 44)

A compound of claim 44, wherein T is unsubstituted naphthyl, unsubstituted 4-trifluoromethylphenyl, unsubstituted 1,2,3,4-tetrahydroquinolin-7-yl, 1-(3-hydroxypropyl)-3,4-dihydro-2H-quinolin-7-yl, or 1-(2-acetoxy-ethyl)-3,4-dihydro-2H-quinolin-7-yl and W is 2-methoxyphenyl.

### Claim 57

The compound
(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-naphthalen-2-ylmethyl-amine,
(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-(6-methoxy-naphthalen-2-ylmethyl)-amine,
(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-quinolin-7-ylmethyl-amine,
(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-(1,2,3,4-tetrahydro-quinolin-7-ylmethyl)-amine,
(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-methyl-naphthalen-2-ylmethyl-amine,
6-[(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalen-2-ol,
benzofuran-5-ylmethyl-(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amine,
(1H-indol-5-ylmethyl)-(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amine;
6-[(4-[3-(2-methoxy-benzyloxy)-propoxyl]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-1-carboxylic acid methyl ester;
6-[(4-[4-(2-methoxy-benzyloxy)-propoxyl]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-1-carboxylic acid;
naphthalene-1-carboxylic acid (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amide;
6-[(4-{4-[3-(2-methoxy-benyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-2-carboxylic acid methyl ester;
(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-quinolin-7-ylmethyl-amine;
6-[(4-{4-[3-(2-fluoro-benyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-2-carboxylic acid methyl ester;
6-[(4-{4-[3-(2-fluoro-benyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-2-carboxylic acid;
6-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-pyridine-2-carboxylic acid methyl ester;
naphthalene-2-sulfonic acid (4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amide;
(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-(4-fluoro-3-trifluoromethyl-benzyl)-amine;
{3-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-phenoxy}-acetic acid methyl ester;
1-(2-{3-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-phenoxy}-ethyl)-pyrrolidine-2,5-dione;
1-(2-{3-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-phenoxy}-ethyl)-pyrrolidine-2-one;
3-[(1-dimethylcarbamoylmethyl-1, 2, 3, 4-tetrahydro-quinoline-7-carbonyl)-amino]-4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidine-1-carboxylic acid tert-butyl ester; or
[1-(2-dimethylamino-ethyl)-1,2,3,4-tetrahydro-quinolin-7-ylmethyl]-(4-{4-[3-(2-methoxybenzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amine.

### Claim 58 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A pharmaceutical composition comprising a compound of any of claims 1-57, admixed with a pharmaceutically acceptable carrier, diluent, or excipient.

### Claim 59 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of inhibiting renin in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of treating or preventing hypertension in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 61 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of treating or preventing congestive heart failure in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 62 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of treating or preventing stroke in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 63 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of treating or preventing myocardial infarction in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 64 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of treating or preventing glaucoma in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 65 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of providing end organ protection in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 66 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

A method of treating or preventing hyperaldosteronism in a mammal comprising administering to the mammal in need thereof an effective amount of a compound of any of claims 1-57.

### Claim 67 (depends on 1)

A process for preparing a compound of claim 1 comprising the steps of:
a) alkylation of piperidine 1 to afford the intermediate 2 wherein R20 along with the oxygen to which it is attached, is equivalent to -Z-W as defined in claim 1;
61
b) oxidation of 2 to afford the piperidinone intermediate 3;
62
c) contacting 3 with a suitable amine to afford the intermediate 4, wherein R21, along with the nitrogen to which it is attached is equivalent to -Q-T as defined in claim 1;
63
d) deprotection of 4 to afford 5
64
